The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.
about
The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
The long-acting somatostatin a ...... does not prevent tumor growth.
@en
The long-acting somatostatin a ...... does not prevent tumor growth.
@nl
type
label
The long-acting somatostatin a ...... does not prevent tumor growth.
@en
The long-acting somatostatin a ...... does not prevent tumor growth.
@nl
prefLabel
The long-acting somatostatin a ...... does not prevent tumor growth.
@en
The long-acting somatostatin a ...... does not prevent tumor growth.
@nl
P2093
P2860
P356
P1476
The long-acting somatostatin a ...... does not prevent tumor growth.
@en
P2093
Jockenhövel F
Krenning EP
Lamberts SW
Lederbogen S
Olbricht T
Reinwein D
Schmidt-Gayk H
P2860
P2888
P304
P356
10.1007/BF00184589
P577
1994-01-01T00:00:00Z